Literature DB >> 16872707

Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage.

David Lembo1, Manuela Donalisio, Maura Cornaglia, Barbara Azzimonti, Anna Demurtas, Santo Landolfo.   

Abstract

The p53R2 protein is a p53-inducible small subunit of ribonucleotide reductase. It plays a crucial role in p53-dependent cellular response to DNA damage and oxidative stress by providing deoxyribonucleotides (dNTPs) to the DNA repair machinery and by scavenging reactive oxygen species (ROS). To investigate the effects of high-risk human papillomavirus (HPV) oncoproteins on p53R2 expression after DNA damage, we analyzed the p53R2 protein levels in human cells ectopically expressing the HPV-16 E6 and E7 genes, and in the HPV-positive cancer cell lines SiHa, CaSki and HeLa, exposed to adriamycin or to H(2)O(2). We found that in normal cells, p53R2 expression is efficiently induced by both H(2)O(2) and adriamycin, supporting the role of p53R2 in cellular response to oxidative stress. Ectopic expression of E6 impaired p53 and p53R2 induction after DNA damage in human fibroblasts. Moreover, SiHa, CaSki and HeLa cells were unresponsive to H(2)O(2) exposure, and adriamycin induced p53R2 levels only in SiHa cells. Our results imply that high-risk HPV infection may suppress the p53R2-dependent dNTPs supply to the DNA repair system and the ROS scavenging activity; they also suggest that an altered p53R2 response to genotoxins and to oxidative stress may contribute to HPV-induced genetic instability and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16872707     DOI: 10.1016/j.virusres.2006.06.011

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  6 in total

1.  Radiosensitization of human cervical cancer cells by inhibiting ribonucleotide reductase: enhanced radiation response at low-dose rates.

Authors:  Charles A Kunos; Valdir C Colussi; John Pink; Tomas Radivoyevitch; Nancy L Oleinick
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-04       Impact factor: 7.038

2.  Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein.

Authors:  Charles A Kunos; Song-mao Chiu; John Pink; Timothy J Kinsella
Journal:  Radiat Res       Date:  2009-12       Impact factor: 2.841

3.  Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772).

Authors:  P Heffeter; A Popovic-Bijelic; P Saiko; R Dornetshuber; U Jungwirth; N Voevodskaya; D Biglino; M A Jakupec; L Elbling; M Micksche; T Szekeres; B K Keppler; A Gräslund; W Berger
Journal:  Curr Cancer Drug Targets       Date:  2009-08-01       Impact factor: 3.428

4.  Three Prime Repair Exonuclease 1 (TREX1) expression correlates with cervical cancer cells growth in vitro and disease progression in vivo.

Authors:  Bruna Prati; Walason da Silva Abjaude; Lara Termini; Mirian Morale; Suellen Herbster; Adhemar Longatto-Filho; Rafaella Almeida Lima Nunes; Lizeth Carolina Córdoba Camacho; Silvia Helena Rabelo-Santos; Luiz Carlos Zeferino; Francisco Aguayo; Enrique Boccardo
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

5.  ATM Pathway Is Essential for HPV-Positive Human Cervical Cancer-Derived Cell Lines Viability and Proliferation.

Authors:  Walason Abjaude; Bruna Prati; Veridiana Munford; Aline Montenegro; Vanesca Lino; Suellen Herbster; Tatiana Rabachini; Lara Termini; Carlos Frederico Martins Menck; Enrique Boccardo
Journal:  Pathogens       Date:  2022-06-01

6.  Loss of robustness and addiction to IGF1 during early keratinocyte transformation by human Papilloma virus 16.

Authors:  Tamar Geiger; Alexander Levitzki
Journal:  PLoS One       Date:  2007-07-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.